Urinary acetonitrile concentrations correlate with recent smoking behaviour

BJU International

Volumn 95, Issue 3, 2005, Pages 306-309

  Pinggera, Germar Michael ^a   Lirk, Philip ^a   Bodogri, Florian ^a   Herwig, Ralf ^a   Steckel Berger, Gabriele ^b   Bartsch, Georg ^a   Rieder, Josef ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Acetonitrile; Bladder cancer; Carcinogen; Markers; Nicotine; Smoking; Urine

Indexed keywords

ACETONITRILE; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; ENVIRONMENTAL MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTON TRANSFER REACTION MASS SPECTROMETRY; PROTON TRANSPORT; SMOKING; URINALYSIS; URINE LEVEL;

ACETONITRILES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SMOKING;

EID: 14144252989     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05288.x     Document Type: Article

References (28)

1. CDC. Youth tobacco surveillance - United States. MMWR CDC Surveillance Summary 2001. November 2, 2000; 50:1-84
2. USA Department of Health and Human Services. Preventing tobacco use among young people. a report of the Surgeon General. Atlanta: US Department of Health and Human Services, Public Health Service, 1994
3. Escobedo LG, Marcus SE, Holtzman D, Giovino GA. Sports participation, age at smoking initiation, and the risk of smoking among US high school students. JAMA 1993; 269: 1391-5
4. Taioli E, Wynder EL. Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med 1991; 325: 968-9
5. Breslau N, Peterson EL. Smoking cessation in young adults, age at initiation of cigarette smoking and other suspected influences. Am J Public Health 1996; 86: 214-20
6. Ershler J, Leventhal H, Fleming R, Glynn K. The quitting experience for smokers in sixth through twelfth grades. Addict Behav 1989; 14: 365-78
7. Everett SA, Warren CW, Sharp D, Kann L, Husten CG, Crossett LS. Initiation of cigarette smoking and subsequent smoking behavior among U.S. high school students. Prev Med 1999; 29: 327-33
8. Silverman Dt Rothman N, Devesa SS. Epidemiology of bladder cancer. In Syringos KN Skinner DG eds, Bladder Cancer: Biology, Diagnosis and Management. New York: Oxford University Press, 1999: 11-55
9. Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 2000; 205: 105-15
10. Brennan P, Bogillot O, Cordier S et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86: 289-94
11. de Braud F, Maffezzini M, Vitale V et al. Bladder cancer. Crit Rev Oncol Hematol 2002; 41: 89-106
12. Tyrrell AB, MacAirt JG, McCaughey WT. Occupational and non-occupational factors associated with vesical neoplasm in Ireland. J Ir Med Assoc 1971; 64: 213-7
13. Wynder EL, Hoffmann D. Tobacco and tobacco smoke. Semin Oncol 1976; 3: 5-15
14. Burch JD, Rohan TE, Howe GR et al. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989; 44: 622
15. Houeto P, Hoffman JR, Got P, Dang Vu B, Baud FJ. Acetonitrile as a possible marker of current cigarette smoking. Hum Exp Toxicol 1997; 16: 658-61
16. Lindinger W, Hansel A, Jordan A. On-line monitoring of volatile organic compounds at ppbv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research. Int J Mass Spectrom Ion Processes 1998; 173: 191-241
17. Rieder J, Prazeller P, Boehler M, Lirk P, Lindinger W, Amann A. Online monitoring of air quality at the postanesthetic care unit by proton-transfer-reaction mass spectrometry. Anesth Analg 2001; 92: 389-92
18. Karl T, Prazeller P, Mayr D et al. Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. J Appl Physiol 2001; 91: 762-70
19. Rieder J, Lirk P. Ebenbichler C et al. Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wien Klin Wochenschr 2001; 113: 181-5
20. Dalhamn T, Edfors ML, Rylander R. Mouth adsorption of various compounds in cigarette smoke. Arch Environ Health 1968; 16: 831-5
21. USEPA. Chemical Hazard Information Profiles. EPA-560. 1980; 11-80-011:9
22. Silverman Dt Rothman N, Devesa SS. Epidemiology of bladder cancer. In Syringos KN, Skinner DG eds, Bladder Cancer: Biology, Diagnosis, and Management. New York: Oxford University Press, 1999: 11-55
23. Silverman DT, Morrison AS, Devesa SS, Bladder cancer. In Schottenfeld D, Fraumeni JF Jr eds, Cancer Epidemiology and Prevention 2005; in press
24. Vineis P, Kogevinas M, Simonato L et al. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000; 63: 103-10.
25. Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 1995; 103 (Suppl. 8): 131-41
26. Pozzani UC, Carpenter CP, Palm PE et al. An investigation of mammalian toxicity of acetonitrile. J Occup Med 1959; 1: 634-42
27. Dalhamn T, Edfors ML, Rylander R. Retention of cigarette smoke components in human lungs. Arch Environ Health 1968; 17: 746-8
28. Lirk P, Bodrogi F, Deibl M et al. Quantification of recent smoking behaviour using proton transfer reaction-mass spectrometry (PTR-MS) Wien Klin Wochenschr 2004; 31: 21-5